✦ LIBER ✦

How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy

✍ Scribed by Martin J. N. Weinans; Annemarie M. G. Huijssoon; Tjeerd Tymstra; Mignon C. F. Gerrits; Johan R. Beekhuis; Albert Mantingh

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 54 KB
Volume: 20
Category: Article
ISSN: 0197-3851
DOI: 10.1002/1097-0223(200009)20:9<705::aid-pd904>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for Down syndrome using urine

Screening for Down syndrome using urine hCG free β-subunit in the second trimester of pregnancy

✍ Laurence A. Cole; Melissa Jacobs; Taichi Isozaki; Glenn E. Palomaki; Ray O. Baha 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

Human chorionic gonadotropin (hCG) free beta-subunit levels were determined in 709 control and 13 Down syndrome urine samples from the second trimester of pregnancy. Results were normalized to urine creatinine concentration and converted to multiples of the unaffected pregnancy medium (MOM). The con

Second-trimester prenatal screening for

Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

In a group of 26 524 control pregnancies and a group of 3728 pregnancies affected by one or more of the pregnancy complications of low birthweight, intra-uterine growth restriction (IUGR), preterm delivery and stillbirth, I have compared the relative risk of occurrence of these complications in preg

SP1 in pregnancies with Down syndrome in

SP1 in pregnancies with Down syndrome in the first trimester of pregnancy

✍ N. J. Wald; H. C. Watt; B. Norgaard-Pedersen; M. Christiansen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

We conducted a study to determine the value of serum pregnancy-specific beta-1-glycoprotein (Schwangerschafts protein 1, SP1) as an antenatal screening test for Down syndrome in the first trimester. Serum samples collected from women at 8 to 14 weeks of pregnancy, immediately prior to having a chori

Maternal serum prostate-specific antigen

Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy

✍ N. J. Wald; A. K. Hackshaw; E. P. Diamandis; D. N. Melegos 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

It has been suggested that high levels of maternal serum prostate-specific (PSA) may be associated with fetal Down syndrome. We retrieved stored blood samples from 102 singleton Down syndrome pregnancies at 8-14 weeks' gestation and 99 at 15-22 weeks' gestation, together with samples from five unaff

Maternal serum screening for trisomy 18

Maternal serum screening for trisomy 18 in the first trimester of pregnancy

✍ Roberto Biagiotti; Ettore Cariati; Laura Brizzi; Gino Cappelli; Alberino D'Agata 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

The aim of this study was to evaluate the feasibility of first-trimester biochemical screening for trisomy 18, by using pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (hCG) in combination with maternal age. Maternal serum levels of PAPP-A and free beta-hCG

Women's opinions and the implications of

Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome

✍ L. H. Kornman; M. J. M. Wortelboer; J. R. Beekhuis; L. P. Morssink; A. Mantingh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Two groups of pregnant women were questioned regarding their opinions on serum screening for Down's syndrome in the first trimester of pregnancy. One group comprised 83 women attending our antenatal clinic who were questioned at the time of the existing second-trimester screening test. Seventy-six p